Effect of Tadalafil in Chronic Obstructive Lung Disease Patients Suffering From Secondary Pulmonary Hypertension
Status:
Withdrawn
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
Tadalafil may lower the pulmonary artery pressure in patients with Chronic Obstructive Lung
Disease and secondary pulmonary hypertension and thereby improve patients quality of life.